<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>24(4)</volume><submitter>Merali S</submitter><funding>Bristol-Myers Squibb</funding><pubmed_abstract>&lt;h4>Objective&lt;/h4>To assess the effect of activated charcoal on the single-dose pharmacokinetics of mavacamten when administered 2 h or 6 h after mavacamten dosing.&lt;h4>Methods&lt;/h4>In this open-label, randomized, parallel-group study, healthy adults were randomized into three groups to receive mavacamten 15 mg alone or mavacamten 15 mg plus activated charcoal 50 g administered either 2 h or 6 h after mavacamten dosing. Pharmacokinetic parameters were derived from plasma concentration-time data using noncompartmental methods.&lt;h4>Results&lt;/h4>Of the 45 participants randomized, 37 completed the study. When activated charcoal was administered 2 h after mavacamten dosing, mavacamten absorption and exposure were reduced compared with when mavacamten was administered alone: the area under the conce</pubmed_abstract><journal>American journal of cardiovascular drugs : drugs, devices, and other interventions</journal><pagination>569-575</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11233281</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effect of Activated Charcoal on Mavacamten Pharmacokinetics in Healthy Participants.</pubmed_title><pmcid>PMC11233281</pmcid><pubmed_authors>Simmons T</pubmed_authors><pubmed_authors>Murthy B</pubmed_authors><pubmed_authors>Chao L</pubmed_authors><pubmed_authors>Attanasio M</pubmed_authors><pubmed_authors>Merali S</pubmed_authors><pubmed_authors>Zhao A</pubmed_authors><pubmed_authors>Sychterz C</pubmed_authors><pubmed_authors>Chiang M</pubmed_authors><pubmed_authors>Perera V</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effect of Activated Charcoal on Mavacamten Pharmacokinetics in Healthy Participants.</name><description>&lt;h4>Objective&lt;/h4>To assess the effect of activated charcoal on the single-dose pharmacokinetics of mavacamten when administered 2 h or 6 h after mavacamten dosing.&lt;h4>Methods&lt;/h4>In this open-label, randomized, parallel-group study, healthy adults were randomized into three groups to receive mavacamten 15 mg alone or mavacamten 15 mg plus activated charcoal 50 g administered either 2 h or 6 h after mavacamten dosing. Pharmacokinetic parameters were derived from plasma concentration-time data using noncompartmental methods.&lt;h4>Results&lt;/h4>Of the 45 participants randomized, 37 completed the study. When activated charcoal was administered 2 h after mavacamten dosing, mavacamten absorption and exposure were reduced compared with when mavacamten was administered alone: the area under the conce</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2026-05-29T11:59:13.377Z</modification><creation>2025-04-04T11:25:04.404Z</creation></dates><accession>S-EPMC11233281</accession><cross_references><pubmed>38926266</pubmed><doi>10.1007/s40256-024-00659-z</doi></cross_references></HashMap>